AddLife AB

Equities

ALIF B

SE0014401378

Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm 11:29:54 2024-04-26 am EDT 5-day change 1st Jan Change
98.65 SEK +2.02% Intraday chart for AddLife AB +0.46% -9.83%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : AddLife AB, Q1 2024 Earnings Call, Apr 24, 2024
AddLife AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Nordic Shares Rose Monday; FastPartner Series A Topped Leaders DJ
Transcript : AddLife AB, 2023 Earnings Call, Feb 02, 2024
Addlife AB Proposes Dividend for the Year Ended December 31, 2023 CI
AddLife AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
AddLife to Start Trade Union Negotiations for Planned Shutdown of Camanio Operations MT
Nordic Shares Rose Wednesday; Hagar Hf. Topped Leaders DJ
Nordic Stocks Dropped Monday; Saab AB Series B Fell Furthest DJ
Transcript : AddLife AB, Nine Months 2023 Earnings Call, Oct 26, 2023
AddLife AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : AddLife AB - Analyst/Investor Day
Nordic Stocks Decreased Monday; Bakkafrost Posted Biggest Loss DJ
Transcript : AddLife AB, H1 2023 Earnings Call, Jul 14, 2023
Tranche Update on AddLife AB (OM:ALIF B)'s Equity Buyback Plan announced on October 28, 2022. CI
AddLife AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
MGI and AddLife AB Announce Strategic Collaboration for Expanded Distribution of MGI products in the Nordic Region CI
Addlife AB Declares Dividend CI
AddLife AB's Equity Buyback announced on October 28, 2022, has expired with 110,000 shares, representing 0.09% for SEK 11.45 million. CI
Transcript : AddLife AB, Q1 2023 Earnings Call, Apr 26, 2023
AddLife AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Transcript : AddLife AB, 2022 Earnings Call, Feb 02, 2023
AddLife AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 CI
Tranche Update on AddLife AB (OM:ALIF B)'s Equity Buyback Plan announced on October 28, 2022. CI
AddLife AB Proposes Dividend for the Year Ended December 31, 2022 CI
Chart AddLife AB
More charts
AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
98.65 SEK
Average target price
137 SEK
Spread / Average Target
+38.87%
Consensus
  1. Stock Market
  2. Equities
  3. ALIF B Stock
  4. News AddLife AB
  5. AddLife to Start Trade Union Negotiations for Planned Shutdown of Camanio Operations